Takeda Hits Accord With Suit Over Actos ANDA

Law360, New York (September 14, 2011, 3:36 PM EDT) -- Takeda Pharmaceutical Co. Ltd. hit Accord Healthcare Inc. with a patent infringement lawsuit Monday in New York federal court, striking back against the generic-drug maker’s bid to produce its own version of the blockbuster diabetes drug Actos.

Accord is the latest in a series of drugmakers targeted by Takeda over their attempts to produce generic versions of Actos, as the Japanese firm works to stave off generic competition until at least August 2012.

In the Monday complaint, Takeda said Accord’s submission of an abbreviated new drug...
To view the full article, register now.